Men with PCa have a 4-fold increased risk of suicidal death within 3 months of diagnosis compared to men who have other solid cancers.
Every 1 mg/dL increase in serum phosphorus level was linked with 36% greater odds of kidney failure among non-dialysis CKD patients.
This laboratory measure could be useful in treatment decision algorithms.
High phosphate levels are associated with 3.3-fold increased odds of 28-day in-hospital mortality.
The technique, with cognitive assistance, identified recurrent tumors in 80% of patients.